Bionano Genomics Inc reports results for the quarter ended in September - Earnings Summary

Bionano Genomics

03/11/2022 21:03

* Bionano Genomics Inc  BNGO.OQ  reported a quarterly
adjusted
loss of 11 cents​​ per share for the quarter ended in September.
The mean expectation of three analysts for the quarter was for a
loss of 11 cents per share.
    * Revenue rose 55.1% to $7.22 million from a year ago;
analysts
expected $6.79 million. 
    * Bionano Genomics Inc's reported EPS for the quarter was a
loss
of 11 cents​.
    * The mean earnings estimate of analysts had fallen by
about 27.3%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Bionano Genomics Inc shares had risen by 21.9% this
quarter and
lost 25.4% so far this year.
    * The company reported a quarterly loss of $31.81 million.
    * Wall Street's median 12-month price target for Bionano
Genomics
Inc is $12.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 3 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 09:03 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.11          -0.11          Met
 Jun. 30 2022      -0.09          -0.11          Missed
 Mar. 31 2022      -0.07          -0.11          Missed
 Dec. 31 2021      -0.06          -0.08          Missed